Nutriband Inc. NTRB · Stock Open Nutriband Inc. in new tab
Nutriband Inc. Analysis (NTRB)
Is Nutriband Inc. a good investment? Nutriband Inc. (NTRB) is currently trading at 5.77 USD.
Earnings Schedule: Nutriband Inc. is expected to release its next earnings report on Dec. 7, 2026. The market consensus estimate for Forward EPS is -0.23.
Investor FAQ
Does Nutriband Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nutriband Inc.?
Nutriband Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Dec. 7, 2026. The company currently has a trailing EPS of -0.53.
Company Profile
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 12, 2022 | 1.17 |
Community Discussion